On a year-on-year (YoY) basis, the company’s net profit rose 1.12%, while revenue dipped 1.05% in Q4 FY25. Profit before tax (PBT) fell 9.1% YoY to Rs 212.66 crore during the quarter.
Total expenses increased 2.08% YoY to Rs 798.10 crore. The cost of raw and packing materials consumed rose 6.95% YoY to Rs 175.40 crore, while employee benefits expense declined 17.84% YoY to Rs 49.37 crore in the same period.
On a full-year basis, the company's net profit jumped 7.18% to Rs 636.59 crore on a 3.07% rise in revenue to Rs 3,374.42 crore in FY25 over FY24.
Meanwhile, the company’s board has recommended a final dividend of Rs 65 per equity share, amounting to a total payout of Rs 210.99 crore, subject to shareholder approval at the 61st Annual General Meeting. If approved, the dividend will be disbursed between 27 August and 23 September 2025.
Procter & Gamble Hygiene and Health Care is engaged in the manufacturing and selling of branded packaged fast-moving consumer goods in the femcare and healthcare businesses.